COMMUNIQUÉS West-GlobeNewswire

Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement
03/09/2026
RAANANA, ISRAEL, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced [...]
Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events
03/09/2026
Pilot Tests Humanoid Robots as Presenters, Hosts, and Brand Ambassadors Before Live Audiences, Extending Robot Capabilities Beyond One-on-One Interaction into Dynamic, Audience-Facing Environments; Onconetix Entered [...]
Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
03/09/2026
NORTHFIELD, Ill., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, chief executive officer, and Mike Drazin, chief financial officer, are scheduled to present at [...]
Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference
03/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct [...]
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03/09/2026
BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
03/09/2026
BURLINGTON, MA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced [...]
Adneuris Therapeutics to Present at PAINWeek 2026
03/09/2026
Adneuris will share new abuse potential data for cebranopadol that demonstrates that its abuse potential may be lower than schedule IV pain drugs Previously announced Phase 3 studies have demonstrated that the Company’s [...]
Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
03/09/2026
Agreement Grants Kala Exclusive U.S. Rights to Market and Distribute Virotek's Ophthalmology Genomic Testing Program ARLINGTON, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Kala Bio, Inc. (Nasdaq: KALA) ("Kala") and [...]
Scancell to Present at the H.C. Wainwright 28th Annual Global Investment Conference
03/09/2026
OXFORD, United Kingdom and BURLINGTON, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Scancell Holdings plc (AIM: SCLP) , a late-stage clinical immuno-oncology company developing active immunotherapies designed to enhance [...]
Claris Bio to Participate in Upcoming Investor Conferences
03/09/2026
JERSEY CITY, N.J., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Claris Biotherapeutics, Inc. , a late-stage biopharmaceutical company dedicated to advancing transformative therapies for sight-threatening conditions where limited [...]
SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company
03/09/2026
NORTH PALM BEACH, Fla., Sept. 03, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments [...]
Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference
03/09/2026
TORONTO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI [...]
Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
03/09/2026
WAYNE, Pa., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026
03/09/2026
Revenue increase driven by significant growth in the United States and other strategic markets NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “ [...]
Quince Therapeutics to Participate in September 2026 Investor Conferences
03/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for [...]
Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference
03/09/2026
GAITHERSBURG, Md., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that [...]
Northwestern Medicine Bronzeville Outpatient Center Celebrates One Year of Providing High-Quality Care Closer to Home
03/09/2026
Northwestern Medicine Bronzeville Outpatient Center now serves as a hub for health, wellness and community engagement for residents of Bronzeville and surrounding neighborhoods CHICAGO, Sept. 03, 2026 (GLOBE NEWSWIRE [...]
Ovid Therapeutics to Participate in Upcoming Investor Conferences
03/09/2026
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant unmet need, today [...]
Cadrenal Therapeutics to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
03/09/2026
PONTE VEDRA, Fla., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing specialized therapies for critical care cardiology and orphan [...]

Pages